WP
PLRX icon

Woodline Partners’s Pliant Therapeutics PLRX Stock Holding History

Woodline Partners’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Sell
1,666,830
-359,361
-18% -$454K 0.01% 802
2025
Q4 		$2.47M Sell
2,026,191
-2,478,626
-55% -$3.72M 0.01% 745
2025
Q3 		$6.67M Buy
4,504,817
+2,156,291
+92% +$3.29M 0.03% 510
2025
Q2 		$2.72M Sell
2,348,526
-165,558
-7% -$234K 0.01% 674
2025
Q1 		$3.39M Buy
2,514,084
+2,386,789
+1,875% +$14.5M 0.02% 590
2024
Q4 		$1.68M Buy
127,295
+15,635
+14% +$213K 0.01% 685
2024
Q3 		$1.25M Buy
111,660
+8,037
+8% +$101K 0.01% 498
2024
Q2 		$1.11M Buy
103,623
+3,480
+3% +$44.9K 0.01% 454
2024
Q1 		$1.49M Sell
100,143
-23,947
-19% -$395K 0.01% 443
2023
Q4 		$2.25M Sell
124,090
-312,162
-72% -$4.75M 0.02% 372
2023
Q3 		$7.56M Buy
436,252
+178,754
+69% +$3.1M 0.09% 253
2023
Q2 		$4.67M Buy
+257,498
New +$6.1M 0.06% 302
2021
Q4 		– Sell
-179,993
Closed -$3.04M – 768
2021
Q3 		$3.04M Buy
179,993
+108,330
+151% +$2.3M 0.05% 336
2021
Q2 		$2.09M Buy
+71,663
New +$2.23M 0.04% 350
2020
Q4 		– Sell
-152,000
Closed -$3.44M – 260
2020
Q3 		$3.44M Buy
+152,000
New +$3.8M 0.11% 149

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Woodline Partners's PLRX Position: Q1 2026 in Review

Woodline Partners reduced its Pliant Therapeutics (PLRX) stake by 18% in Q1 2026, selling an estimated $454K and leaving 1,666,830 shares worth $2.1M. The position accounts for 0.01% of the portfolio, ranked #802.

Woodline Partners first reported a position in PLRX in Q3 2020 and has held it in 15 quarters since. The position peaked at $7.56M in Q3 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Woodline Partners held 1,666,830 shares of Pliant Therapeutics worth $2.1M as of Q1 2026.
  • Woodline Partners sold 359,361 Pliant Therapeutics shares in Q1 2026, an estimated $454K.
  • Pliant Therapeutics made up 0.01% of Woodline Partners's portfolio in Q1 2026, its #802 holding.
  • Woodline Partners first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 15 quarters since.
  • Woodline Partners's Pliant Therapeutics position peaked at $7.56M in Q3 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.